Deutsche Bank’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-261,382
| Closed | -$5.08M | – | 5160 |
|
|
2018
Q1 | $5.08M | Sell |
261,382
-203,449
| -44% | -$3.96M | ﹤0.01% | 2186 |
|
|
2017
Q4 | $7.74M | Buy |
464,831
+186,635
| +67% | +$3.11M | 0.01% | 1675 |
|
|
2017
Q3 | $5.65M | Sell |
278,196
-1,167,781
| -81% | -$23.7M | ﹤0.01% | 1825 |
|
|
2017
Q2 | $23.3M | Buy |
1,445,977
+482,322
| +50% | +$7.76M | 0.02% | 860 |
|
|
2017
Q1 | $12.2M | Buy |
963,655
+396,060
| +70% | +$5.01M | 0.01% | 1138 |
|
|
2016
Q4 | $7.52M | Buy |
567,595
+53,303
| +10% | +$706K | 0.01% | 1425 |
|
|
2016
Q3 | $12.2M | Sell |
514,292
-62,358
| -11% | -$1.48M | 0.01% | 1179 |
|
|
2016
Q2 | $16.6M | Buy |
576,650
+330,728
| +134% | +$9.53M | 0.01% | 1008 |
|
|
2016
Q1 | $7.87M | Sell |
245,922
-494,207
| -67% | -$15.8M | 0.01% | 1424 |
|
|
2015
Q4 | $31.6M | Buy |
740,129
+407,867
| +123% | +$17.4M | 0.02% | 725 |
|
|
2015
Q3 | $11.7M | Buy |
332,262
+89,492
| +37% | +$3.15M | 0.01% | 1198 |
|
|
2015
Q2 | $11.1M | Buy |
242,770
+32,287
| +15% | +$1.48M | 0.01% | 1288 |
|
|
2015
Q1 | $9.86M | Sell |
210,483
-32,199
| -13% | -$1.51M | 0.01% | 1345 |
|
|
2014
Q4 | $7.69M | Buy |
242,682
+79,277
| +49% | +$2.51M | ﹤0.01% | 1619 |
|
|
2014
Q3 | $3.87M | Buy |
163,405
+20,419
| +14% | +$484K | ﹤0.01% | 2004 |
|
|
2014
Q2 | $4.29M | Sell |
142,986
-59,183
| -29% | -$1.77M | ﹤0.01% | 1912 |
|
|
2014
Q1 | $5.34M | Sell |
202,169
-122,178
| -38% | -$3.23M | ﹤0.01% | 1776 |
|
|
2013
Q4 | $8.15M | Sell |
324,347
-60,922
| -16% | -$1.53M | 0.01% | 1453 |
|
|
2013
Q3 | $7.89M | Buy |
385,269
+201,464
| +110% | +$4.12M | 0.01% | 1487 |
|
|
2013
Q2 | $3.66M | Buy |
+183,805
| New | +$3.66M | ﹤0.01% | 1812 |
|